世界最新医学信息文摘(连续型电子期刊)
世界最新醫學信息文摘(連續型電子期刊)
세계최신의학신식문적(련속형전자기간)
World Latest Medicine Information
2014年
27期
15-16
,共2页
腰椎间盘突出症%椎间孔镜%老年
腰椎間盤突齣癥%椎間孔鏡%老年
요추간반돌출증%추간공경%노년
intervertebral disc protrusion%transforaminal endoscopic%elderly
目的:观察探究50例老年腰椎间盘突出症患者经皮椎间孔镜治疗的近中期疗效。方法选取2010至2013年于我院就诊的腰椎间盘突出患者100例,将此100例患者随机均分为两组,治疗组行 Petd 治疗,对照组行传统的手术治疗,观察近中期效果。结果治疗组手术时间、术中出血量、住院时间以及围手术期手术 Vas 评分均显著低于手术治疗,且差异有统计学意义,短期治疗效果明显。两组患者术后7天的 Vas 评分均显著低于术前水平,差异有统计学意义,且治疗组术后各时间段的腰腿疼痛评分以及神经功能恢复均优于对照组,中期治疗效果亦较好。结论经皮椎间孔镜治疗老年腰椎间盘突出症患者具有手术伤害性低、术后恢复快、疗效明显等优点,近中期疗效均显著,值得临床推广应用。
目的:觀察探究50例老年腰椎間盤突齣癥患者經皮椎間孔鏡治療的近中期療效。方法選取2010至2013年于我院就診的腰椎間盤突齣患者100例,將此100例患者隨機均分為兩組,治療組行 Petd 治療,對照組行傳統的手術治療,觀察近中期效果。結果治療組手術時間、術中齣血量、住院時間以及圍手術期手術 Vas 評分均顯著低于手術治療,且差異有統計學意義,短期治療效果明顯。兩組患者術後7天的 Vas 評分均顯著低于術前水平,差異有統計學意義,且治療組術後各時間段的腰腿疼痛評分以及神經功能恢複均優于對照組,中期治療效果亦較好。結論經皮椎間孔鏡治療老年腰椎間盤突齣癥患者具有手術傷害性低、術後恢複快、療效明顯等優點,近中期療效均顯著,值得臨床推廣應用。
목적:관찰탐구50례노년요추간반돌출증환자경피추간공경치료적근중기료효。방법선취2010지2013년우아원취진적요추간반돌출환자100례,장차100례환자수궤균분위량조,치료조행 Petd 치료,대조조행전통적수술치료,관찰근중기효과。결과치료조수술시간、술중출혈량、주원시간이급위수술기수술 Vas 평분균현저저우수술치료,차차이유통계학의의,단기치료효과명현。량조환자술후7천적 Vas 평분균현저저우술전수평,차이유통계학의의,차치료조술후각시간단적요퇴동통평분이급신경공능회복균우우대조조,중기치료효과역교호。결론경피추간공경치료노년요추간반돌출증환자구유수술상해성저、술후회복쾌、료효명현등우점,근중기료효균현저,치득림상추엄응용。
Objective to investigate recent mid-term efficacy of percutaneous transforaminal endoscopic discectomy in treatment of 50 cases of elderly patients with lumbar intervertebral disc protrusion. Methods 100 patients with lumbar intervertebral disc protrusion selected from 2010 to 2013 in our hospital were randomly divided into two groups. treatment group underwent Petd therapy, while the control group underwent conventional surgery. the recent mid-term effects were observed. Results in the treatment group, the operation time, length of hospital stay and perioperative surgical Vas scores were significantly lower than that in control group, and the difference was statistically significant. Conclusion percutaneous transforaminal endoscopic discectomy in treatment of elderly patients has the advantages of low surgical injury, quick recovery and significant efficacy. And recent mid-term efficacy was significant. It is worthy of clinical application.